| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 09/08/2011 | US20110218197 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
| 09/08/2011 | US20110218192 Inhibitors Of Beta-Secretase |
| 09/08/2011 | US20110218189 PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS |
| 09/08/2011 | US20110218185 Azolotriazinone melanin concentrating hormone receptor-1 antagonists |
| 09/08/2011 | US20110218183 Fused Bicyclic mTOR Inhibitors |
| 09/08/2011 | US20110218178 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 09/07/2011 | EP2363394A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders |
| 09/07/2011 | EP2152713B1 Pyrazolopyrrolidines as inhibitors of gamma secretase |
| 09/07/2011 | EP1812007B1 Pyridazine compounds and methods |
| 09/07/2011 | CN1582150B Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 09/07/2011 | CN102177161A Pyrimidinyl pyridone inhibitors of JNK |
| 09/07/2011 | CN102177153A Compositions and methods for treating alcohol use disorders, pain and other diseases |
| 09/07/2011 | CN102174048A Novel polymorphic form beta of soporifics |
| 09/07/2011 | CN102174017A Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 09/07/2011 | CN101133061B Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-ce]indol-6-one |
| 09/06/2011 | US8013170 Substituted pyrrolo[1,2-d][1,4]-diazonines and treatment of brain damage |
| 09/06/2011 | US8013149 Methods and intermediates for the synthesis of porphyrins |
| 09/06/2011 | US8012995 Pharmaceutically active sulfonamide derivatives |
| 09/06/2011 | US8012987 Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith |
| 09/06/2011 | US8012975 Antitumoral analogs of ET-743 |
| 09/06/2011 | US8012966 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors |
| 09/06/2011 | US8012960 Heterocyclic aspartyl protease inhibitors |
| 09/06/2011 | US8012959 Diaminopyrimidinecarboxamide derivative |
| 09/06/2011 | US8012957 Tetrahydro-1H-1,2,6-triaza-azulene cannabinoid modulators |
| 09/06/2011 | CA2406872C A process for the preparation of decahydro-2a,4a,6a,8a-tetraazacyclopent[fg]acenaphthylene and functionalized derivatives |
| 09/06/2011 | CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/01/2011 | WO2011106414A1 Inhibitors of beta-secretase |
| 09/01/2011 | WO2011106340A1 Pyrazolopyridazine derivatives for the treatment of hepatitis c |
| 09/01/2011 | WO2011105628A1 Pyrazolopyrimidine compounds and their use as pde10 inhibitors |
| 09/01/2011 | WO2011105572A1 Novel heteroaryl derivative |
| 09/01/2011 | WO2011105394A1 Method for producing regulatory dendritic cells |
| 09/01/2011 | WO2011027249A3 Benzimidazole derivatives |
| 09/01/2011 | US20110213149 Process for preparation of (2r)-4-oxo-4-[3- (trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin- 7(8h)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine & new impurities in preparation thereof |
| 09/01/2011 | US20110213147 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 09/01/2011 | US20110213143 Compound having tafia inhibitory activity |
| 09/01/2011 | US20110212971 Diketo fused azolopiperidines and azolopiperazines as anti-hiv agents |
| 09/01/2011 | US20110212967 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors |
| 09/01/2011 | US20110212960 New compounds for the treatment of cns disorder |
| 09/01/2011 | US20110212942 Inhibitors of polo-like kinase |
| 09/01/2011 | US20110212941 Imidazoisoindole Neuropeptide S Receptor Antagonists |
| 09/01/2011 | US20110212938 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |
| 09/01/2011 | US20110212929 Protein Kinase Inhibitors |
| 09/01/2011 | US20110212078 Synthesis and use of heterocyclic antibacterial agents |
| 09/01/2011 | US20110212025 Tspo-targeting compounds and uses thereof |
| 09/01/2011 | CA2791166A1 Pyrazolopyrimidine compounds and their use as pde10 inhibitors |
| 09/01/2011 | CA2790922A1 Method for preparing regulatory dentritic cells |
| 08/31/2011 | EP2361910A1 Compound having tafia inhibitory activity |
| 08/31/2011 | EP2361248A1 Heteroaryl compounds and uses thereof |
| 08/31/2011 | EP2361088A2 Method of inducing cleavage of amyloid precursor protein to form a novel fragment |
| 08/31/2011 | EP2250172B1 Pyrrolopyrazine kinase inhibitors |
| 08/31/2011 | EP2247592B1 Pyrrolopyrazine kinase inhibitors |
| 08/31/2011 | EP2245033B1 Pyrrolopyrazine kinase inhibitors |
| 08/31/2011 | EP2183027B1 Organic compounds |
| 08/31/2011 | EP2173748B1 Indolyl pyrrolidines for the treatment of cancer |
| 08/31/2011 | EP2170891B1 Pyrazolopyrimidinone kinase inhibitor |
| 08/31/2011 | EP2121697B1 Compounds for the treatment of hepatitis c |
| 08/31/2011 | EP1489061B1 Process for producing cyclic compound |
| 08/31/2011 | CN1953981B Method for producing a solution of pure triethylenediamine (TEDA) |
| 08/31/2011 | CN1946726B Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 08/31/2011 | CN102171214A Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) |
| 08/31/2011 | CN102171213A Pyrazolo [3, 4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity |
| 08/31/2011 | CN102171212A Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates and related synthetic processes |
| 08/31/2011 | CN102171211A Piperidine derivatives as JAK3 inhibitors |
| 08/31/2011 | CN102171206A Diazepine and diazocane compounds as MC4 agonists |
| 08/31/2011 | CN102167704A Water-soluble porphyrin gold (III) anticancer compounds and preparation method thereof |
| 08/31/2011 | CN102167703A Flexible multi-arm porphyrin with pyridine groups and synthesis method thereof |
| 08/31/2011 | CN102167702A 3-trifluoromethyl-2,5-diazabicyclo[2.2.1] heptane derivant and preparation method thereof |
| 08/31/2011 | CN102167701A Fluorine-containing diphenyl-pyrrolo-pyrrolidinedione (DPP) pigments and preparation method thereof |
| 08/31/2011 | CN102167700A 3-trifluoromethyl-5-tert-butoxycarbonyl-2,5-diheterobicyclo[2.2.1]heptane and preparation method thereof |
| 08/31/2011 | CN101348501B 2-imino-9-phenyl-1,10-phenanthroline transient metal complex, and preparation and use thereof |
| 08/31/2011 | CN101223167B Novel heteroaryl fused cyclic amines |
| 08/31/2011 | CN101200469B Separation of regioisomers of metal phthalocyanines |
| 08/31/2011 | CN101119968B Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/31/2011 | CN101115719B Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 08/30/2011 | US8008507 Fluorescent diketopyrrolopyrroles |
| 08/30/2011 | US8008505 Indazole or 4,5,6,7-tetrahydro-indazole derivatives |
| 08/30/2011 | US8008491 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders |
| 08/30/2011 | US8008486 Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound |
| 08/30/2011 | US8008332 Substituted indazoles as glucokinase activators |
| 08/30/2011 | US8008312 CXCR4 antagonists for the treatment of HIV infection |
| 08/30/2011 | US8008302 ((2S,3S) N,2-dihydroxy-5-methyl-3-{[4-(2-pyridinyl)-1-piperazinyl]carbonyl}hexanamide; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, stroke, cancer, pre-term labor, endometriosis |
| 08/30/2011 | US8008289 α-aminocyclolactam ligands for G-protein coupled receptors |
| 08/30/2011 | US8008288 Anti-inflammatory A-aminocyclolactam compounds |
| 08/30/2011 | US8008287 Use treating HIV and AIDS; tricyclic compounds such as those based on 5-sulfonamido-9-hydroxy-6,8-dihydrdo-7H-pyrrolo[3,4-g]quinoline-8-one |
| 08/30/2011 | CA2552600C Triaza-cyclopenta[cd]indene derivatives |
| 08/25/2011 | WO2011103524A2 Cyclic tetrapeptides and therapeutic applications thereof |
| 08/25/2011 | WO2011103423A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors |
| 08/25/2011 | WO2011103202A2 Androgen receptor modulators and uses thereof |
| 08/25/2011 | WO2011103128A1 Treatment of metabolic syndrome with novel amines |
| 08/25/2011 | WO2011102964A1 Heterocycles as potassium channel modulators |
| 08/25/2011 | WO2011102640A2 Method for preparing sitagliptin and amine salt intermediates used therein |
| 08/25/2011 | WO2011102348A1 Hydrazide chelate complex compound and optical recording medium using same |
| 08/25/2011 | WO2011101740A1 Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine |
| 08/25/2011 | WO2011101640A1 Fused heterocyclic compounds for use in the treatment of malaria |
| 08/25/2011 | WO2011101417A1 Deuterated pyrrolopyrimidine compounds as inhibitors of cdk4/6 |
| 08/25/2011 | WO2011101409A1 Pyrrolopyrimidine compounds as inhibitors of cdk4/6 |
| 08/25/2011 | WO2011101304A2 Piperidine derivatives |
| 08/25/2011 | WO2011101297A1 Substituted spiroindolinones |
| 08/25/2011 | WO2011101161A1 Pyrazole derivatives as jak inhibitors |
| 08/25/2011 | WO2011100838A1 Derivatives of 1-phenyl-1,5-dihydro-benzo[b] [1.4]diazepine-2.4-dione as inhibitors of hiv replication |